Skip to main navigation Skip to search Skip to main content

Design, synthesis, and biological activity of novel Magmas inhibitors

  • Yale University
  • Albert Einstein College of Medicine

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Magmas (mitochondria associated, granulocyte-macrophage colony stimulating factor signaling molecule), is a highly conserved and essential gene, expressed in all cell types. We designed and synthesized several small molecule Magmas inhibitors (SMMI) and assayed their effects on proliferation in yeast. We found that the most active compound 9 inhibited growth at the 4 μM scale. This compound was shown by fluorometric titration to bind to Magmas with a K d = 33 μM. Target specificity of the lead compound was established by demonstrating direct binding of the compound to Magmas and by genetic studies. Molecular modeling suggested that the inhibitor bound at the predicted site in Magmas.

Original languageEnglish
Pages (from-to)3479-3482
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Issue number11
DOIs
StatePublished - Jun 1 2011

Keywords

  • Chemical genetics
  • Guanidine pharmacophores
  • LRD-limited
  • Magmas inhibitors
  • Mitochondrial protein import
  • Molecular modeling
  • Pam16
  • Rational design
  • Tim16

Fingerprint

Dive into the research topics of 'Design, synthesis, and biological activity of novel Magmas inhibitors'. Together they form a unique fingerprint.

Cite this